Literature DB >> 16952773

Treatment-resistant depression in adolescents: recognition and management.

David A Brent1, Boris Birmaher.   

Abstract

Approximately 20% of adolescents experience at least one depressive episode by the time they enter their adult years. For most adolescents, depression, although serious, either remits spontaneously or responds to treatment. For a smaller but significant proportion of adolescents, however, depression can be long-lasting and relatively unresponsive to initial treatment. In this article the authors provide an operational definition of treatment-resistant depression, identify factors associated with treatment nonresponse, describe an approach to the management of treatment-resistant depression, and advance suggestions for promising avenues of research.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16952773     DOI: 10.1016/j.chc.2006.05.001

Source DB:  PubMed          Journal:  Child Adolesc Psychiatr Clin N Am        ISSN: 1056-4993


  11 in total

1.  Characteristics of depression among offspring at high and low familial risk of bipolar disorder.

Authors:  Rasim Somer Diler; Tina R Goldstein; Danella Hafeman; Brian Thomas Rooks; Dara Sakolsky; Benjamin I Goldstein; Kelly Monk; Mary Beth Hickey; David Axelson; Satish Iyengar; Boris Birmaher
Journal:  Bipolar Disord       Date:  2017-06-14       Impact factor: 6.744

Review 2.  Annual Research Review: Defining and treating pediatric treatment-resistant depression.

Authors:  Jennifer B Dwyer; Argyris Stringaris; David A Brent; Michael H Bloch
Journal:  J Child Psychol Psychiatry       Date:  2020-02-04       Impact factor: 8.982

Review 3.  From TADS and SOFTADS to TORDIA and beyond: what's new in the treatment of adolescent depression?

Authors:  Zheya Jenny Yu; Christopher J Kratochvil; Ronald A Weller; Mira Mooreville; Elizabeth B Weller
Journal:  Curr Psychiatry Rep       Date:  2010-04       Impact factor: 5.285

4.  Depressed adolescents demonstrate greater subgenual anterior cingulate activity.

Authors:  Tony T Yang; Alan N Simmons; Scott C Matthews; Susan F Tapert; Guido K Frank; Amanda Bischoff-Grethe; Amy E Lansing; Jing Wu; Gregory G Brown; Martin P Paulus
Journal:  Neuroreport       Date:  2009-03-04       Impact factor: 1.837

5.  Gastrodin ameliorates depressive-like behaviors and up-regulates the expression of BDNF in the hippocampus and hippocampal-derived astrocyte of rats.

Authors:  Ruiguo Zhang; Zhengwu Peng; Huaihai Wang; Fen Xue; Yihuan Chen; Ying Wang; Huaning Wang; Qingrong Tan
Journal:  Neurochem Res       Date:  2013-11-30       Impact factor: 3.996

Review 6.  Vagus nerve stimulation: can it be used in adolescents or children with treatment-resistant depression?

Authors:  Zheya Jenny Yu; Ronald A Weller; Kendra Sandidge; Elizabeth B Weller
Journal:  Curr Psychiatry Rep       Date:  2008-04       Impact factor: 5.285

7.  Differential Anterior Cingulate Activity during Response Inhibition in Depressed Adolescents with Bipolar and Unipolar Major Depressive Disorder.

Authors:  Rasim Somer Diler; Lisa A Pan; Annamaria Segreti; Cecile D Ladouceur; Erika Forbes; Soledad Romero Cela; Jorge R C Almeida; Boris Birmaher; David A Axelson; Mary L Phillips
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2014-02

8.  Efficacy of Interpretation Bias Modification in Depressed Adolescents and Young Adults.

Authors:  Jamie A Micco; Aude Henin; Dina R Hirshfeld-Becker
Journal:  Cognit Ther Res       Date:  2014-04-01

9.  Rosmarinic acid ameliorates depressive-like behaviors in a rat model of CUS and Up-regulates BDNF levels in the hippocampus and hippocampal-derived astrocytes.

Authors:  Xiang Jin; Peng Liu; Fengchi Yang; Ya-Hong Zhang; Danmin Miao
Journal:  Neurochem Res       Date:  2013-06-12       Impact factor: 3.996

10.  Magnetic Resonance Imaging-Guided, Open-Label, High-Frequency Repetitive Transcranial Magnetic Stimulation for Adolescents with Major Depressive Disorder.

Authors:  Christopher A Wall; Paul E Croarkin; Mandie J Maroney-Smith; Laura M Haugen; Joshua M Baruth; Mark A Frye; Shirlene M Sampson; John D Port
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-02-05       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.